Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 306 is a processed pseudogene related to the 5S ribosomal RNA gene family. As a pseudogene, it is a non-functional genetic element derived from retrotransposition of the parental 5S rRNA gene. It does not encode functional ribosomal RNA, nor does it participate in ribosome structure or function. Processed pseudogenes generally lack promoters and regulatory elements and are not transcribed as functional RNAs, though a growing body of evidence suggests that some pseudogenes may participate in gene regulatory networks through antisense transcription or as competing endogenous RNAs in rare cases. There is currently no evidence that RNA5SP306 serves such biological roles[2][5]. It is not considered a therapeutic target, enzyme, receptor, or other druggable protein family member.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 306 (RNA5SP306).